1. Home
  2. CULP vs EDSA Comparison

CULP vs EDSA Comparison

Compare CULP & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

N/A

Current Price

$3.64

Market Cap

43.8M

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

N/A

Current Price

$4.14

Market Cap

51.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CULP
EDSA
Founded
1972
2015
Country
United States
Canada
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
51.5M
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CULP
EDSA
Price
$3.64
$4.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
91.3K
73.8K
Earning Date
03-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
47.06
N/A
EPS
0.47
N/A
Revenue
$203,482,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.42
N/A
P/E Ratio
$7.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.70
$0.72
52 Week High
$4.75
$20.32

Technical Indicators

Market Signals
Indicator
CULP
EDSA
Relative Strength Index (RSI) 60.01 29.70
Support Level $3.19 $1.34
Resistance Level $4.02 $5.10
Average True Range (ATR) 0.18 0.34
MACD 0.04 -0.03
Stochastic Oscillator 50.59 10.66

Price Performance

Historical Comparison
CULP
EDSA

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: